BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PharSafer® - Global Clinical and Post Marketing Drug Safety - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://pharsafer.com
X-WR-CALDESC:Events for PharSafer® - Global Clinical and Post Marketing Drug Safety
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zagreb
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260624
DTEND;VALUE=DATE:20260626
DTSTAMP:20260528T114311Z
CREATED:20260528T114311Z
LAST-MODIFIED:20260528T114311Z
UID:3135-1782259200-1782431999@pharsafer.com
SUMMARY:Drug Safety Symposium India 2026
DESCRIPTION:BIO International Convention 2026 \nDate: 24th–25th June 2026 \nLocation: Mumbai\, India \nPharSafer® is pleased to confirm our participation as a Gold Partner at the 6th Edition Drug Safety Symposium India 2026 (DSS India)\, one of the region’s leading events dedicated to modern pharmacovigilance\, patient safety\, regulatory strategy\, and drug safety operations. \nBringing together senior pharmacovigilance\, regulatory\, quality\, and clinical leaders from across the pharmaceutical industry\, DSS India provides an important platform for discussing the evolving operational and compliance challenges shaping global patient safety today. \nExclusive Speaker Session \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for a thought-provoking session: \n“Patient Safety Under Pressure – Are We Still Waiting for the Balloon to Pop?” \nModern pharmacovigilance was built on the lessons learned from some of the industry’s biggest patient safety failures. Since then\, regulation\, oversight\, and safety systems have evolved dramatically – but so has the complexity surrounding them. \nToday’s PV environments are under constant pressure from growing case volumes\, fragmented global processes\, increasing regulatory expectations\, outsourcing models\, and rising operational burden. More data does not always mean better oversight – and in many organisations\, the pressure points are becoming harder to ignore. \nThis session will explore whether modern pharmacovigilance is genuinely reducing risk\, or whether new operational pressures are quietly building beneath the surface. Discussions will cover the realities affecting today’s safety teams\, including aggregate reporting\, data consistency\, medical interpretation\, inspection readiness\, and the evolving role of automation and AI within patient safety operations. \nUsing the concept of a “balloon under pressure”\, the session will challenge whether current pharmacovigilance models are truly sustainable long term – or simply delaying the next burst. \nMeet the PharSafer Team in Mumbai \nOur team will be available throughout DSS India 2026 to discuss the growing operational pressures facing modern pharmacovigilance environments and how organisations can build more scalable\, sustainable\, and inspection-ready safety operations. \nAreas of discussion include: \n\nClinical & Post-Marketing Pharmacovigilance\nAggregate Reporting & Medical Review\nGlobal Regulatory Strategy & Compliance\nInspection Readiness & Quality Oversight\nOperational Scalability & Outsourcing Models\nPharmacovigilance Automation & Workflow Optimisation\nRAPTAR® Safety Automation Solutions\n\nWhy Meet with PharSafer? \nAs a global CRO specialising in pharmacovigilance\, regulatory strategy\, medical services\, and safety technology\, PharSafer supports organisations across the full product lifecycle – from early clinical development through to post-marketing surveillance. \nWith increasing operational complexity across modern safety environments\, our focus remains on helping organisations improve consistency\, strengthen oversight\, reduce operational burden\, and maintain sustainable compliance without compromising patient safety. \nSchedule a Meeting \nIf you are attending DSS India 2026 and would like to discuss your organisation’s pharmacovigilance challenges\, operational goals\, or regulatory strategy\, we welcome the opportunity to connect with you in Mumbai. \nTo arrange a meeting with the PharSafer team\, please contact us directly or schedule your meeting with us in advance. \nWe look forward to meeting you at DSS India 2026.
URL:https://pharsafer.com/event/drug-safety-symposium-india-2026/
LOCATION:Courtyard by Marriott Mumbai International Airport\, CTS 215\, Andheri - Kurla Rd\, Mumbai\, Maharashtra\, 400093\, India
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2026/05/Drug-Safety-Symposium.png
ORGANIZER;CN="Eminence Group Ventures":MAILTO:suryansh@eminencemedia.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20260528T111535Z
CREATED:20260528T105705Z
LAST-MODIFIED:20260528T111535Z
UID:3128-1782086400-1782431999@pharsafer.com
SUMMARY:BIO International Convention 2026
DESCRIPTION:BIO International Convention 2026 \nDate: June 22nd-25th\, 2026 \nLocation: San Diego\, California\, USA \nPharSafer® is delighted to confirm our participation in the BIO International Convention 2026\, the world’s largest and most comprehensive biotechnology event\, bringing together global leaders across biotech\, pharmaceutical\, regulatory\, investment\, and innovation sectors. \nVisit PharSafer at Booth #5554 \nOur team will be available throughout the event and welcomes the opportunity to discuss your organisation’s challenges and explore tailored solutions across: \n\nClinical & Post-Marketing Pharmacovigilance\nGlobal Regulatory Strategy & Risk Management\nAuditing\, Inspection Readiness & Quality Support\nMedical Affairs & Medical Information Services\nPharmacovigilance Automation & Innovation via RAPTAR®\nSupport for Rare Disease\, Biologics & Advanced Therapies\n\nAs BIO 2026 continues to place increasing emphasis on partnering and pre-arranged meetings\, PharSafer® will also be actively engaging through the BIO Partnering platform throughout the event. \nWhether you are an emerging biotech preparing for clinical progression\, a growing pharmaceutical company seeking scalable global safety support\, or an established organisation exploring operational efficiencies and innovation\, our team would be pleased to connect. \nWant to Schedule a Meeting with PharSafer?  \nTo ensure dedicated one-to-one time with our team during BIO 2026\, we encourage attendees to arrange meetings in advance via the BIO Partnering platform or by contacting us directly ahead of the event. \nSchedule a meeting with PharSafer® to discuss your organisation’s requirements and discover how our global expertise\, regulatory insight\, and innovation-led approach can support your development and commercialisation objectives. \nWe look forward to connecting with you in San Diego for another exciting and impactful BIO International Convention.
URL:https://pharsafer.com/event/bio-international-convention-2026/
LOCATION:San Diego Convention Center\, 111 Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2026/05/BIO-International.png
ORGANIZER;CN="BIO US":MAILTO:CustomerCare@bio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260528T113945Z
CREATED:20260527T163518Z
LAST-MODIFIED:20260528T113945Z
UID:3106-1780963200-1781222399@pharsafer.com
SUMMARY:World Orphan Drug Congress USA 2026
DESCRIPTION:World Orphan Drug Congress USA 2026 \nDate: June 9th-11th\, 2026 \nLocation: Boston\, USA \nPharSafer® is pleased to confirm our participation as a Gold Sponsor at the World Orphan Drug Congress USA 2026\, one of the leading global events focused on orphan drugs\, rare disease development\, regulatory strategy\, and patient-centred innovation. \nBringing together pharmaceutical companies\, biotech organisations\, regulators\, patient advocacy groups\, and industry experts from across the rare disease landscape\, WODC USA provides an important platform for discussing the evolving challenges surrounding orphan-drug development and long-term patient safety. ​ \nExclusive Speaker Session \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for an insightful speaker session within the Clinical Development & Regulatory track: \n\n“What Makes Orphan Drug Pharmacovigilance Different? Real-World Challenges and Practical Solutions” \n\nPharmacovigilance for orphan and ultra-orphan therapies carries the same regulatory expectations as any other product – if not more – yet the path to achieving compliant\, sustainable safety oversight is often significantly more challenging. \nIn this session\, Dr. Ladds will explore the practical realities of pharmacovigilance in rare disease settings\, including how limited clinical exposure\, fragmented real-world evidence\, dispersed patient populations\, and complex disease backgrounds can make safety interpretation disproportionately difficult. \nKey discussion areas will include: \n\nWhy traditional pharmacovigilance approaches often struggle in orphan-drug settings\nThe challenges created by limited datasets\, translation barriers\, and complex disease profiles\nPractical\, proportionate PV approaches that support compliance without overwhelming smaller teams\nBuilding credible\, defensible safety oversight where every individual case can significantly influence patient understanding and programme confidence\nThe wider role of pharmacovigilance in supporting regulatory confidence\, programme sustainability\, and long-term development success\n\nIdeal for: Pharmacovigilance leaders\, regulatory professionals\, clinical development teams\, biotech innovators\, medical affairs professionals\, and organisations involved in orphan and ultra-orphan drug development. \nAttendees will leave with a deeper understanding of the operational and strategic challenges unique to orphan-drug pharmacovigilance\, alongside practical insight into designing sustainable safety frameworks for low-data environments. \n​Connect with PharSafer® in Boston \nOur senior team will be available throughout the event and would welcome the opportunity to discuss your organisation’s challenges and explore tailored support across: \n\nClinical & Post-Marketing Pharmacovigilance\nRare Disease & Orphan Drug Safety Strategy\nGlobal Regulatory Strategy & Risk Management Planning\nAuditing\, Training & Inspection Readiness\nMedical Affairs & Safety Communication\nSafety Automation & Workflow Innovation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure dedicated time with our team during the event\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with industry colleagues and partners in Boston for what promises to be another valuable and insightful event. \nNote: For more information about the event\, please visit: World Orphan Drug Congress 2026.
URL:https://pharsafer.com/event/world-orphan-drug-congress-usa-2026/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2026/05/WODC.png
ORGANIZER;CN="Terrapinn - WODC US":MAILTO:enquiry.usa@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251118
DTEND;VALUE=DATE:20251120
DTSTAMP:20250729T092722Z
CREATED:20250729T092614Z
LAST-MODIFIED:20250729T092722Z
UID:2935-1763424000-1763596799@pharsafer.com
SUMMARY:Advanced Therapies Congress US
DESCRIPTION:Advanced Therapies Congress US 2025\n \nDate: November 18th–19th\, 2025 \nLocation: Philadelphia\, USA \nPharSafer® is excited to join industry leaders at the forefront of cell\, gene\, and tissue-based innovation at the Advanced Therapies Congress US — a key event shaping the future of advanced medicinal products (ATMPs).​ \nExclusive Speaker Session in Innovation Track \nPresented by Dr. Graeme Ladds\, CEO of PharSafer®: \n“Advanced Vigilance for Advanced Therapies” \nAs ATMPs continue to transform treatment possibilities\, they demand a new era of long-term\, agile safety frameworks. In this session\, we will address: \n\nThe unique vigilance challenges of the ATMP landscape\nDesigning scalable\, modern safety frameworks\nAligning long-term monitoring with regulatory success\nCollaborative approaches for cost-effective innovation\n\nWho should attend: ATMP developers\, regulatory strategists\, pharmacovigilance teams\, and advanced therapy innovators. \n​Meet PharSafer® at Booth #309 \nOur expert team will be available throughout the event to discuss how PharSafer® supports advanced therapy developers with: \n\nGlobal Pharmacovigilance for Cell & Gene Therapies\nRisk Management & Regulatory Strategy\nInspection Readiness & Global Labelling Support\nScalable Safety Solutions for ATMP Portfolios\nAdvanced Safety Automation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure a dedicated time with our experts\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with you in Philadelphia for an inspiring and impactful event. \nNote: For more information about the event\, please visit: Advanced Therapies USA
URL:https://pharsafer.com/event/advanced-therapies-congress-us/
LOCATION:Pennsylvania Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/07/Advanced-Therapies-Congress-US.png
ORGANIZER;CN="Terrapinn - Advanced Therapies":MAILTO:enquiry.usa@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251107
DTSTAMP:20250625T125337Z
CREATED:20250625T125337Z
LAST-MODIFIED:20250625T125337Z
UID:2900-1762214400-1762473599@pharsafer.com
SUMMARY:World Drug Safety Congress USA 2025
DESCRIPTION:World Drug Safety Congress Americas 2025 \nDate: November 4th–6th\, 2025 \nLocation: Boston\, USA \nPharSafer® is thrilled to participate in the premier global gathering for drug safety and pharmacovigilance professionals.​ \nExclusive Speaker Session in AI & Automation Track \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for his keynote presentation: \n“Automation in Pharmacovigilance – Friend or Fiend?” \nIn this focused session\, Dr. Ladds will examine the double-edged role of automation and AI in pharmacovigilance. Attendees will gain insights into: \n\nThe benefits and pitfalls of integrating automated systems into safety oversight\n\nHow PharSafer’s RAPTAR® supports compliance while staying efficient \n\n\nReal-world examples showcasing both success and cautionary tales \n\n\nPreparing for the future of AI-human collaboration in drug safety \n\n\nWho should attend: Pharmacovigilance professionals\, AI strategists\, regulatory affairs leaders\, clinical safety teams\, and tech-forward biotech stakeholders. \n\n​Meet PharSafer® at Booth #632 \nOur senior leadership team will be on-site to discuss how PharSafer® can support your global safety strategy\, including: \n\n\nClinical & Post-Marketing Pharmacovigilance \n\n\nGlobal Regulatory Strategy & Risk Management \n\n\nAudit Preparation\, Training & Inspection Readiness \n\n\nMedical Affairs & Safety Communications \n\nAdvanced Safety Automation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure a dedicated time with our experts\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with you in Boston for an inspiring and impactful event. \nNote: For more information about the event\, please visit: World Drug Safety Congress 2025.
URL:https://pharsafer.com/event/world-drug-safety-congress-usa-2025/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/06/WDSC-US.png
ORGANIZER;CN="Terrapinn - WDSC US":MAILTO:enquiry.usa@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251009
DTSTAMP:20250729T093524Z
CREATED:20250729T093524Z
LAST-MODIFIED:20250729T093524Z
UID:2938-1759795200-1759967999@pharsafer.com
SUMMARY:World Drug Safety Congress EU 2025
DESCRIPTION:World Drug Safety Congress Europe 2025 \nDate: October 7th–8th\, 2025 \nLocation: Amsterdam\, Netherlands \nPharSafer® is proud to participate in the leading European forum for pharmacovigilance\, drug safety\, and regulatory innovation.​ \nExclusive Speaker Session in AI & Automation Track \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for his keynote presentation: \n“Lifting the Lid on PV Inspection Findings – What Can Automation Do to Improve the Current Situation?” \nPV inspections often reveal recurring issues — but what if automation could prevent them before they arise? \nIn this session\, Dr. Ladds will explore: \n\nCommon PV inspection findings and root causes\nThe role of intelligent automation in driving compliance\nHow technology can improve operational efficiency without losing oversight\nReal-world applications and lessons learned\n\nWho should attend: Pharmacovigilance leaders\, QA and compliance professionals\, regulatory teams\, and those exploring PV automation strategies. \n​Meet PharSafer® at Booth #10 \nOur senior team will be available to discuss PharSafer’s global expertise in: \n\nInspection Readiness & PV Quality Systems\nEnd-to-End Pharmacovigilance Services\nGlobal Safety Governance & Risk Mitigation\nAdvanced Safety Automation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure a dedicated time with our experts\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with you in Amsterdam for insightful discussions that explore new possibilities in drug safety. \nNote: For more information about the event\, please visit: World Drug Safety Europe 2025.
URL:https://pharsafer.com/event/world-drug-safety-congress-eu-2025/
LOCATION:Amsterdam RAI\, Europaplein 24\, Amsterdam\, 1078 GZ\, Netherlands
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/06/WDSC-EU.png
ORGANIZER;CN="Terrapinn - WDSC EU":MAILTO:enquiry.uk@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250616
DTEND;VALUE=DATE:20250620
DTSTAMP:20260528T104153Z
CREATED:20250505T100833Z
LAST-MODIFIED:20260528T104153Z
UID:2885-1750032000-1750377599@pharsafer.com
SUMMARY:BIO International Convention 2025
DESCRIPTION:BIO International Convention 2025 \nDate: June 16th–19th\, 2025 \nLocation: Boston\, Massachusetts\, USA \nPharSafer is excited to confirm our participation in the BIO International Convention 2025\, the world’s largest and most comprehensive biotechnology event\, bringing together over 20\,000 industry leaders from across the globe. \nVisit PharSafer at Booth #2379 \nOur senior team will be available throughout the event and welcomes the opportunity to discuss your organisation’s challenges and explore tailored solutions across: \n\nClinical & Post-Marketing Pharmacovigilance\nGlobal Regulatory Strategy & Risk Management Planning\nAuditing\, Training & Inspection Readiness\nMedical Affairs & Safety Communication\nSafety Automation with RAPTAR Reporting\n\nWant to guarantee one-on-one time with our team?  \nTo ensure dedicated time with our experts\, we encourage you to schedule your meeting with us in advance. \nSchedule your meeting today to discuss your specific needs and discover how PharSafer can help you navigate the evolving regulatory landscape. \nWe look forward to connecting with you in Boston for an inspiring and impactful event.
URL:https://pharsafer.com/event/bio-international-convention/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/05/BIO25.png
ORGANIZER;CN="BIO US":MAILTO:CustomerCare@bio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250422
DTEND;VALUE=DATE:20250425
DTSTAMP:20250321T172032Z
CREATED:20250321T172032Z
LAST-MODIFIED:20250321T172032Z
UID:2875-1745280000-1745539199@pharsafer.com
SUMMARY:World Orphan Drug Congress USA 2025
DESCRIPTION:World Orphan Drug Congress USA 2025 \nDate: April 22nd–24th\, 2025 \nLocation: Boston\, USA \nPharSafer® is delighted to confirm our participation in the World Orphan Drug Congress USA 2025\, one of the foremost global events dedicated to orphan drug development\, rare disease research\, and regulatory innovation.​ \nExclusive Speaker Session \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for his keynote presentation: \n“Safety & Compliance Without Borders: The Orphan Drug Safety Regulatory Checklist” \nIn this must-attend session\, Dr. Ladds will share expert guidance on building a compliant global safety strategy for orphan and ultra-orphan drug development — from early clinical trials to long-term post-marketing surveillance. Drawing from decades of regulatory experience\, this talk explores: \n\nNavigating regulatory divergences across the FDA\, EMA\, MHRA\, Health Canada\, and more\nReal-world case studies and practical tools to transform global compliance into a competitive advantage\nStrategies to manage compassionate use\, rare patient populations\, and long-term safety\nHow to leverage automation to ensure efficiency and data integrity\n\nIdeal for: Regulatory affairs professionals\, rare disease developers\, PV leaders\, clinical operations teams\, and biotech innovators looking to expand globally while remaining compliant. \nAttendees will leave with a deeper understanding of global safety challenges — and a clear checklist to enhance compliance readiness across international markets. \n​Connect with PharSafer® in Boston \nOur senior team will be available throughout the event and would welcome the opportunity to discuss your organisation’s challenges and explore tailored solutions across: \n\nClinical & Post-Marketing Pharmacovigilance\nGlobal Regulatory Strategy & Risk Management Planning\nAuditing\, Training & Inspection Readiness\nMedical Affairs & Safety Communication\nSafety Automation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure a dedicated time with our experts\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with you in Boston for an inspiring and impactful event. \nNote: For more information about the event\, please visit: World Orphan Drug Congress 2025.
URL:https://pharsafer.com/event/world-orphan-drug-congress-usa-2025/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/03/Europharm.png
ORGANIZER;CN="Terrapinn - WODC US":MAILTO:enquiry.usa@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250410
DTEND;VALUE=DATE:20250412
DTSTAMP:20250321T172110Z
CREATED:20250321T165444Z
LAST-MODIFIED:20250321T172110Z
UID:2870-1744243200-1744415999@pharsafer.com
SUMMARY:Europharm International Business Meeting 2025
DESCRIPTION:Europharm International Business Meeting 2025 \nDate: April 10th–11th\, 2025 \nLocation: Athens\, Greece \nPharSafer® is excited to announce our participation in the upcoming Europharm International Business Meeting 2025\, hosted by Europharm SMC. This esteemed annual gathering brings together key decision-makers from the pharmaceutical industry to discuss innovation\, regulatory strategies\, and global healthcare trends.​ \nWhy Engage with PharSafer? \nWith over two decades of global experience\, PharSafer® assists pharmaceutical\, biotech\, and medical device companies in confidently navigating the evolving regulatory landscape. Our core services include:​ \n\nComprehensive Pharmacovigilance: Ensuring patient safety throughout the product lifecycle\, encompassing both clinical and post-marketing phases.​\nRisk Management Planning: Developing and implementing Risk Management Plans (RMPs)\, Risk Evaluation and Mitigation Strategies (REMS)\, and global risk minimisation strategies.​\nRegulatory Strategy & Compliance: Providing guidance across various markets\, including the EU\, UK\, US\, and emerging regions\, to ensure adherence to regulatory requirements.​\nMedical Affairs & Safety Services: Supporting scientific\, medical\, and safety communication needs to maintain the highest standards of medical information.​\nAuditing\, Training & Inspection Readiness: Offering Good Pharmacovigilance Practice (GVP) auditing\, Standard Operating Procedure (SOP) development\, mock inspections\, and team upskilling to ensure compliance and preparedness.​\nInformatics & Systems: Overseeing pharmacovigilance databases\, implementing RAPTAR® automation\, and utilising Individual Case Safety Report (ICSR) processing tools to enhance efficiency.​\n\nExclusive Speaker Session \nWe invite you to attend a presentation by our CEO\, Dr. Graeme Ladds\, titled:​ \n“What’s Stopping You? Turning Global Compliance Hurdles into Market Opportunities — Your 5-Year Plan” \nIn this session\, Dr. Ladds will share practical insights on transforming regulatory and pharmacovigilance challenges into strategic advantages\, positioning your organisation for success in a complex global market.​ \nConnect with PharSafer® in Athens \nOur senior team will be available throughout the event and welcomes the opportunity to discuss your challenges and explore tailored solutions for your global safety and compliance needs.​ \nSchedule a Meeting \nTo ensure a dedicated time for discussion\, please schedule your meeting with us in advance.​ \nWe look forward to connecting with you in Athens for a productive and insightful event! \n​ \nNote: For more information about the event\, please visit: Europharm International Business Meeting 2025.
URL:https://pharsafer.com/event/europharm-international-business-meeting-2025/
LOCATION:Royal Olympic Hotel Athens\, 28 Athanasiou Diakou Street\, Athens\, 117 43\, Greece
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/03/Europharm-1.png
ORGANIZER;CN="Europharm SMC":MAILTO:ave@europharmsmc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250313
DTEND;VALUE=DATE:20250316
DTSTAMP:20250224T112719Z
CREATED:20250224T105315Z
LAST-MODIFIED:20250224T112719Z
UID:2818-1741824000-1742083199@pharsafer.com
SUMMARY:BIOCHINA 2025
DESCRIPTION:BIOCHINA 2025 \nDate: March 13th–15th\, 2025 \nLocation: Shanghai\, China \nPharSafer is excited to attend BIOCHINA 2025\, one of China’s leading events for the life sciences and biotechnology industries. As a global expert in drug safety\, regulatory strategy\, and compliance\, we look forward to engaging with Chinese pharmaceutical\, biotech\, and medical device companies to discuss strategies for entering global markets while ensuring regulatory excellence. \nWhy Meet with PharSafer? \nWe help companies navigate complex global safety and compliance regulations\, offering expert support in: \n✔️ Pharmacovigilance & Risk Management – From early development to post-marketing surveillance.✔️ Regulatory Strategy – Guidance on meeting UK\, EU\, US\, and global market entry requirements.✔️ RAPTAR® Reporting – Advanced automation for case processing across Drugs\, Devices\, Vaccines\, Cosmetics\, and Drug-Device Combinations.✔️ Medical Affairs & Training – Ensuring compliance with expert-led consulting and training. \nConnect with PharSafer at BIOCHINA 2025 \nOur team will be attending throughout the event and would love to connect. If you’re interested in discussing your pharmacovigilance and compliance needs\, let’s arrange a time to meet. \nWant to secure a dedicated time to chat? \nSchedule your meeting today and let’s discuss how we can support your success in global drug safety\, regulatory compliance\, and market expansion. \nWe look forward to meeting you in Shanghai!
URL:https://pharsafer.com/event/biochina-2025/
LOCATION:Suzhou International Expo Center\, 688 East Suzhou Avenue\, Suzhou\, Jiangsu\, 215028\, China
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2024/04/BIOCHINA25.png
ORGANIZER;CN="BIOCHINA 2025":MAILTO:biochina@enmore.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250127
DTEND;VALUE=DATE:20250130
DTSTAMP:20250224T101414Z
CREATED:20240411T144317Z
LAST-MODIFIED:20250224T101414Z
UID:2536-1737936000-1738195199@pharsafer.com
SUMMARY:DIA Global Pharmacovigilance and Risk Management Strategies Conference 2025
DESCRIPTION:DIA Global Pharmacovigilance and Risk Management Strategies Conference 2025 \nDate: January 27th–29th\, 2025 \nLocation: Baltimore\, Maryland\, USA \nPharSafer is thrilled to be attending the DIA Global Pharmacovigilance and Risk Management Strategies Conference 2025\, and look forward to meeting with pharmacovigilance professionals and thought leaders to discuss the future of global drug safety and risk management. \nVisit PharSafer at Booth #102 \nWe are excited to showcase our comprehensive pharmacovigilance services and innovative solutions at Booth #102. \nDiscover how PharSafer’s global expertise and advanced RAPTAR® Reporting solution can revolutionise safety case capture\, processing\, and follow-up for: \n\nDrugs\nCosmetics\nDevices\nVaccines\nDrug-Device Combinations\nPregnancy Reports\n\nConnect with PharSafer \nStop by our booth to meet our team and explore how PharSafer can support your safety and compliance goals with tailored solutions and cutting-edge technology. \nWant to guarantee one-on-one time with our team?  \nSchedule your meeting today to discuss your specific needs and discover how PharSafer can help you navigate the evolving regulatory landscape. \nWe look forward to seeing you at DIA GPVRMS 2025 and exploring how we can work together to enhance compliance for your products.
URL:https://pharsafer.com/event/dia-global-pharmacovigilance-and-risk-management-strategies-conference-2025/
LOCATION:Hilton Baltimore Inner Harbor\, 401 W Pratt Street\, Baltimore\, MD\, 21201\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2024/04/DIA-GPVRMS.png
ORGANIZER;CN="DIA GPVRMS":MAILTO:CustomerService@DIAglobal.org
END:VEVENT
END:VCALENDAR